Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in U.S. Healthy Participants
Clinical trial NCT07618715 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07618715
- Sponsor
- Neurodawn Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2026-08-31
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.